BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33002292)

  • 1. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.
    Shinohara T; Urayama KY; Watanabe A; Akahane K; Goi K; Huang M; Kagami K; Abe M; Sugita K; Okada Y; Goto H; Minegishi M; Iwamoto S; Inukai T
    J Cell Mol Med; 2020 Nov; 24(22):12920-12932. PubMed ID: 33002292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B-cell precursor acute lymphoblastic leukaemia.
    Huang M; Inukai T; Kagami K; Abe M; Shinohara T; Watanabe A; Somazu S; Oshiro H; Goi K; Goto H; Minegishi M; Iwamoto S; Urayama KY; Sugita K
    Hematol Oncol; 2018 Feb; 36(1):245-251. PubMed ID: 28850694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
    Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia.
    Rainer J; Lelong J; Bindreither D; Mantinger C; Ploner C; Geley S; Kofler R
    Mol Endocrinol; 2012 Jan; 26(1):178-93. PubMed ID: 22074950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
    Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
    Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
    Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
    Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-503 Contributes to Glucocorticoid Sensitivity in Acute Lymphoblastic Leukaemia via Targeting WNT3A.
    Tian C; Liu L; Zheng M; Ye Z; Chen R; Lan X
    Folia Biol (Praha); 2021; 67(5-6):199-207. PubMed ID: 35439853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
    Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
    Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
    Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
    J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.
    van Galen JC; Kuiper RP; van Emst L; Levers M; Tijchon E; Scheijen B; Waanders E; van Reijmersdal SV; Gilissen C; van Kessel AG; Hoogerbrugge PM; van Leeuwen FN
    Blood; 2010 Jun; 115(23):4810-9. PubMed ID: 20354172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells.
    Bindreither D; Ecker S; Gschirr B; Kofler A; Kofler R; Rainer J
    BMC Genomics; 2014 Aug; 15(1):662. PubMed ID: 25103118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced alterations in mitochondrial membrane properties and respiration in childhood acute lymphoblastic leukemia.
    Eberhart K; Rainer J; Bindreither D; Ritter I; Gnaiger E; Kofler R; Oefner PJ; Renner K
    Biochim Biophys Acta; 2011 Jun; 1807(6):719-25. PubMed ID: 21237131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia.
    El-Fayoumi R; Hagras M; Abozenadaha A; Bawazir W; Shinawi T
    Asian Pac J Cancer Prev; 2018 May; 19(5):1415-1423. PubMed ID: 29802709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of polymorphisms in the drug transporter, ABCB1 on the toxicity of glucocorticoids in Saudi children with acute lymphoblastic leukaemia.
    ElFayoumi RI; Hagras MM; Abozenadaha A; Gari M; Abosoudah I; Shinawi T; Mirza T; Bawazir W
    Pharmacol Rep; 2019 Feb; 71(1):90-95. PubMed ID: 30508724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
    Li Y; Wei Y; Gu L
    Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
    Hui PY; Chen YH; Qin J; Jiang XH
    Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia.
    Gasic V; Zukic B; Stankovic B; Janic D; Dokmanovic L; Lazic J; Krstovski N; Dolzan V; Jazbec J; Pavlovic S; Kotur N
    Radiol Oncol; 2018 Sep; 52(3):296-306. PubMed ID: 30210047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.